Seroprevalence of anti-EBV IgG among various age groups from Khon Kaen province, Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 17, 2015, Pages 7583-7587

  Suntornlohanakul, Rabporn ^a   Wanlapakorn, Nasamon ^a   Vongpunsawad, Sompong ^a   Thongmee, Thanunrat ^a   Chansaenroj, Jira ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Adult; Anti EBV IgG; Children; Seroprevalence; Thailand

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; BLOOD; CHILD; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; THAILAND; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; THAILAND; YOUNG ADULT;

EID: 84949883616     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.17.7583     Document Type: Article

References (32)

1. Balfour HH Jr (2014). Progress, prospects, and problems in Epstein-Barr virus vaccine development. Curr Opin Virol, 6, 1-5.
2. Balfour HH Jr, Sifakis F, Sliman JA, et al (2013). Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis, 208, 1286-93.
3. Biggar RJ, Henle W, Fleisher G, et al (1978). Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer, 22, 239-43.
4. Chan KH, Tam JS, Peiris JS, et al (2001). Epstein-Barr virus (EBV) infection in infancy. J Clin Virol, 21, 57-62.
5. Chatproedprai S, Chongsrisawat V, Chatchatee P, et al (2007). Declining trend in the seroprevalence of infection with hepatitis A virus in Thailand. Ann Trop Med Parasitol, 101, 61-8.
6. Chen CY, Huang KY, Shen JH, et al (2015). A large-scale seroprevalence of epstein-barr virus in taiwan. PLoS One, 10, 115836.
7. Cheng CC, Chang LY, Shao PL, et al (2007). Clinical manifestations and quantitative analysis of virus load in Taiwanese children with Epstein-Barr virus-associated infectious mononucleosis. J Microbiol Immunol Infect, 40, 216-21.
8. Cohen JI, Bollard CM, Khanna R, et al (2008). Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas. Leuk Lymphoma, 49, 27-34.
9. Condon LM, Cederberg LE, Rabinovitch MD, et al (2014). Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment. Clin Infect Dis, 59, 501-8.
10. De Paschale M, Clerici P (2012). Serological diagnosis of Epstein-Barr virus infection: Problems and solutions. World J Virol, 1, 31-43.
11. Dohno S, Maeda A, Ishiura Y, et al (2010). Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants. Pediatr Int, 52, 536-40.
12. Dowd JB, Palermo T, Brite J, et al (2013). Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One, 8, 64921.
13. Haque T, Iliadou P, Hossain A, et al (1996). Seroepidemiological study of Epstein-Barr virus infection in Bangladesh. J Med Virol, 48, 17-21.
14. Hjalgrim H, Askling J, Sørensen P, et al (2000). Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J Natl Cancer Inst, 92, 1522-8.
15. Hsu JL, Glaser SL (2000). Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol, 34, 27-53.
16. Kangro HO, Osman HK, Lau YL, et al (1994). Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol, 43, 91-6.
17. Kimura H, Ito Y, Suzuki R, et al (2008). Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol, 18, 305-19.
18. Leogrande G, Jirillo E (1993). Studies on the epidemiology of child infections in the Bari area (south Italy). VII. Epidemiology of Epstein-Barr virus infections. Eur J Epidemiol, 9, 368-72.
19. Mekmullica J, Kritsaneepaiboon S, Pancharoen C (2003). Risk factors for Epstein-Barr virus infection in Thai infants. Southeast Asian J Trop Med Public Health, 34, 395-7.
20. Mitarnun W, Pradutkanchana J, Ishida T (2004). Epstein-Barr virus-associated nodal malignant lymphoma in Thailand. Asian Pac J Cancer Prev, 5, 268-72.
21. Nystad TW, Myrmel H (2007). Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM-and EBNA-1-antibodies and suspected infectious mononucleosis. J Clin Virol, 38, 292-7.
22. Pancharoen C, Bhattarakosol P, Thisyakorn U. Seroprevalence of Epstein-Barr virus infection in Thai children. J Med Assoc Thai, 84, 850-4.
23. Pancharoen C, Mekmullica J, Chinratanapisit S, et al (2001). Antibody among children in various age groups in Bangkok, Thailand. Asian Pac J Allergy Immunol, 19, 135-7.
24. Piriou E, Asito AS, Sumba PO, et al (2012). Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis, 205, 906-13.
25. Poovorawan Y, Tantimongkolsuk C, Chongsrisawat V, et al (1997). High prevalence of Epstein-Barr virus antibody among school children of the low to middle socio-economic class in Bangkok, Thailand. Southeast Asian J Trop Med Public Health, 28, 434-5.
26. Sakulwira K, Theamboonlers A, Oraveerakul K, et al (2004). Orangutan herpesvirus. J Med Primatol, 33, 25-9.
27. Sokal EM, Hoppenbrouwers K, Vandermeulen C, et al (2007). Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J Infect Dis, 196, 1749-53.
28. Takeuchi K, Tanaka-Taya K, Kazuyama Y, et al (2006). Prevalence of Epstein-Barr virus in Japan: Trends and future prediction. Pathol Int, 56, 112-6.
29. Tiwawech D, Srivatanakul P, Karalak A, et al (2005). Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 6, 270-5.
30. VanDevanter DR, Warrener P, Bennett L, et al (1996). Detection and analysis of diverse herpesviral species by consensus primer PCR. J Clin Microbiol, 34, 1666-71.
31. Xiong G, Zhang B, Huang MY, et al (2014). Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence. PLoS One, 9, e99857.
32. Yuan Huang, Cong Wei, Kun Zheng, et al (2013). The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections. Virol J, 10, 55.